These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37379215)

  • 1. Loss of Mettl3 enhances liver tumorigenesis by inducing hepatocyte dedifferentiation and hyperproliferation.
    Wei T; Li J; Zhang J; Zhang Q; Liu X; Chen Q; Wen L; Ma K; Chen W; Zhao J; Zhang C; Huang J; Xie Y; Qin H; Qian D; Liang T
    Cell Rep; 2023 Jul; 42(7):112704. PubMed ID: 37379215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte-specific METTL3 ablation by Alb-iCre mice (GPT), but not by Alb-Cre mice (JAX), resulted in acute liver failure (ALF) and postnatal lethality.
    Huang S; Li Y; Wang B; Zhou Z; Li Y; Shen L; Cong J; Han L; Xiang X; Xia J; He D; Zhao Z; Zhou Y; Li Q; Dai G; Shen H; Lin T; Wu A; Jia J; Xiao D; Li J; Zhao W; Lin X
    Aging (Albany NY); 2024 Apr; 16(8):7217-7248. PubMed ID: 38656880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBXIP drives metabolic reprogramming in hepatocellular carcinoma cells via METTL3-mediated m6A modification of HIF-1α.
    Yang N; Wang T; Li Q; Han F; Wang Z; Zhu R; Zhou J
    J Cell Physiol; 2021 May; 236(5):3863-3880. PubMed ID: 33305825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SUMO1 modification of methyltransferase-like 3 promotes tumor progression via regulating Snail mRNA homeostasis in hepatocellular carcinoma.
    Xu H; Wang H; Zhao W; Fu S; Li Y; Ni W; Xin Y; Li W; Yang C; Bai Y; Zhan M; Lu L
    Theranostics; 2020; 10(13):5671-5686. PubMed ID: 32483411
    [No Abstract]   [Full Text] [Related]  

  • 5. An Alternatively Spliced Variant of METTL3 Mediates Tumor Suppression in Hepatocellular Carcinoma.
    Xu RY; Ding Z; Zhao Q; Ke TY; Chen S; Wang XY; Wang YY; Sheng MF; Wang W; Long N; Shen YX; Xu YZ; Shao W
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL3 and STAT3 form a positive feedback loop to promote cell metastasis in hepatocellular carcinoma.
    Liu B; Cao J; Wu B; Hao K; Wang X; Chen X; Shen Z
    Cell Commun Signal; 2023 May; 21(1):121. PubMed ID: 37231451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 promotes m6A hypermethylation of RBM14 via YTHDF1 leading to the progression of hepatocellular carcinoma.
    Hu J; Yang L; Peng X; Mao M; Liu X; Song J; Li H; Chen F
    Hum Cell; 2022 Nov; 35(6):1838-1855. PubMed ID: 36087219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA m
    Lin Z; Niu Y; Wan A; Chen D; Liang H; Chen X; Sun L; Zhan S; Chen L; Cheng C; Zhang X; Bu X; He W; Wan G
    EMBO J; 2020 Jun; 39(12):e103181. PubMed ID: 32368828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3 Regulates Liver Homeostasis, Hepatocyte Ploidy, and Circadian Rhythm-Controlled Gene Expression in Mice.
    Barajas JM; Lin CH; Sun HL; Alencastro F; Zhu AC; Aljuhani M; Navari L; Yilmaz SA; Yu L; Corps K; He C; Duncan AW; Ghoshal K
    Am J Pathol; 2022 Jan; 192(1):56-71. PubMed ID: 34599880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STK33 promotes hepatocellular carcinoma through binding to c-Myc.
    Yang T; Song B; Zhang J; Yang GS; Zhang H; Yu WF; Wu MC; Lu JH; Shen F
    Gut; 2016 Jan; 65(1):124-33. PubMed ID: 25398772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma.
    Liu GM; Zeng HD; Zhang CY; Xu JW
    Dig Dis Sci; 2021 Apr; 66(4):1110-1126. PubMed ID: 32333311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2.
    Chen M; Wei L; Law CT; Tsang FH; Shen J; Cheng CL; Tsang LH; Ho DW; Chiu DK; Lee JM; Wong CC; Ng IO; Wong CM
    Hepatology; 2018 Jun; 67(6):2254-2270. PubMed ID: 29171881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein arginine methyl transferase 1- and Jumonji C domain-containing protein 6-dependent arginine methylation regulate hepatocyte nuclear factor 4 alpha expression and hepatocyte proliferation in mice.
    Zhao J; Adams A; Roberts B; O'Neil M; Vittal A; Schmitt T; Kumer S; Cox J; Li Z; Weinman SA; Tikhanovich I
    Hepatology; 2018 Mar; 67(3):1109-1126. PubMed ID: 29023917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic Akt-FOXO3 loop favors tumor-promoting modes and enhances oxidative damage-associated hepatocellular carcinogenesis.
    Lu M; Hartmann D; Braren R; Gupta A; Wang B; Wang Y; Mogler C; Cheng Z; Wirth T; Friess H; Kleeff J; Hüser N; Sunami Y
    BMC Cancer; 2019 Sep; 19(1):887. PubMed ID: 31488102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
    Xie W; Ma LL; Xu YQ; Wang BH; Li SM
    Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microtubule associated protein 9 inhibits liver tumorigenesis by suppressing ERCC3.
    Zhang J; Huang JZ; Zhang YQ; Zhang X; Zhao LY; Li CG; Zhou YF; Wei H; Yu J
    EBioMedicine; 2020 Mar; 53():102701. PubMed ID: 32151798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.
    Horie Y; Suzuki A; Kataoka E; Sasaki T; Hamada K; Sasaki J; Mizuno K; Hasegawa G; Kishimoto H; Iizuka M; Naito M; Enomoto K; Watanabe S; Mak TW; Nakano T
    J Clin Invest; 2004 Jun; 113(12):1774-83. PubMed ID: 15199412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mettl3-mediated m
    Dai G; Huang S; Li Y; Tu X; Xia J; Zhou Z; Chen W; Zhang A; Lin J; Li Y; He D; Lin T; Cong J; Lei Y; Han L; Yao Z; Liu W; Zhou Y; Li Q; Li J; Zhang Y; Wu A; Xiao D; Wang W; Zhao W; Jia J; Lin X
    Aging (Albany NY); 2023 Jun; 15(12):5550-5568. PubMed ID: 37335109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The methyltransferase METTL3 promotes tumorigenesis via mediating HHLA2 mRNA m6A modification in human renal cell carcinoma.
    Zhu D; Liu Y; Chen J; Wang Q; Li Y; Zhu Y; Feng J; Jiang J
    J Transl Med; 2022 Jul; 20(1):298. PubMed ID: 35794583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.